Geron Corp (GERN) stock
GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.00+0.06 (+6.17%)
Close on Nov 17, 2026Market cap $642.47MP/E –Yield –
Geron cash
Cash and short-term investments held at the end of each period.
Geron's cash was $62.64M at Jun 30, 2026. For fiscal 2025 it was $77.56M, down 80.9% from the year before. Over ten years it grew 13.8% a year on average. The highest annual figure on record is $406.57M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $77.56M | -80.9% |
| FY2024 | Dec 31, 2024 | $406.57M | +21.8% |
| FY2023 | Dec 31, 2023 | $333.70M | +93.2% |
| FY2022 | Dec 31, 2022 | $172.75M | -6.0% |
| FY2021 | Dec 31, 2021 | $183.72M | -6.4% |
| FY2020 | Dec 31, 2020 | $196.28M | +40.9% |
| FY2019 | Dec 31, 2019 | $139.33M | -14.7% |
| FY2018 | Dec 31, 2018 | $163.29M | +72.5% |
| FY2017 | Dec 31, 2017 | $94.69M | +624.0% |
| FY2016 | Dec 31, 2016 | $13.08M | -38.5% |
| FY2015 | Dec 31, 2015 | $21.25M | -50.4% |
| FY2014 | Dec 31, 2014 | $42.80M | +229.5% |
| FY2013 | Dec 31, 2013 | $12.99M | -41.1% |
| FY2012 | Dec 31, 2012 | $22.06M | +37.0% |
| FY2011 | Dec 31, 2011 | $16.11M | -65.0% |
| FY2010 | Dec 31, 2010 | $45.97M | +32.9% |
| FY2009 | Dec 31, 2009 | $34.60M | -68.4% |
| FY2008 | Dec 31, 2008 | $109.35M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $62.64M | -19.4% |
| Q1 FY2026 | Mar 31, 2026 | $68.90M | -17.7% |
| Q4 FY2025 | Dec 31, 2025 | $77.56M | -80.9% |
| Q3 FY2025 | Sep 30, 2025 | $78.12M | -77.0% |
| Q2 FY2025 | Jun 30, 2025 | $77.73M | -78.6% |
| Q1 FY2025 | Mar 31, 2025 | $83.75M | -81.1% |
| Q4 FY2024 | Dec 31, 2024 | $406.57M | +21.8% |
| Q3 FY2024 | Sep 30, 2024 | $339.77M | +8.4% |
| Q2 FY2024 | Jun 30, 2024 | $362.73M | -2.3% |
| Q1 FY2024 | Mar 31, 2024 | $443.05M | +16.4% |
| Q4 FY2023 | Dec 31, 2023 | $333.70M | +93.2% |
| Q3 FY2023 | Sep 30, 2023 | $313.53M | +61.0% |
| Q2 FY2023 | Jun 30, 2023 | $371.38M | +69.4% |
| Q1 FY2023 | Mar 31, 2023 | $380.74M | +128.4% |
| Q4 FY2022 | Dec 31, 2022 | $172.75M | -6.0% |
| Q3 FY2022 | Sep 30, 2022 | $194.79M | +10.6% |
| Q2 FY2022 | Jun 30, 2022 | $219.29M | +10.6% |
| Q1 FY2022 | Mar 31, 2022 | $166.67M | -21.0% |
| Q4 FY2021 | Dec 31, 2021 | $183.72M | -6.4% |
| Q3 FY2021 | Sep 30, 2021 | $176.12M | -22.6% |
| Q2 FY2021 | Jun 30, 2021 | $198.24M | -9.4% |
| Q1 FY2021 | Mar 31, 2021 | $211.03M | +59.7% |
| Q4 FY2020 | Dec 31, 2020 | $196.28M | +40.9% |
| Q3 FY2020 | Sep 30, 2020 | $227.62M | +64.2% |
| Q2 FY2020 | Jun 30, 2020 | $218.75M | +43.5% |
| Q1 FY2020 | Mar 31, 2020 | $132.12M | -13.1% |
| Q4 FY2019 | Dec 31, 2019 | $139.33M | -14.7% |
| Q3 FY2019 | Sep 30, 2019 | $138.61M | -16.7% |
| Q2 FY2019 | Jun 30, 2019 | $152.49M | +697.2% |
| Q1 FY2019 | Mar 31, 2019 | $151.98M | +1820.9% |
| Q4 FY2018 | Dec 31, 2018 | $163.29M | +72.5% |
| Q3 FY2018 | Sep 30, 2018 | $166.35M | +1579.6% |
| Q2 FY2018 | Jun 30, 2018 | $19.13M | +189.5% |
| Q1 FY2018 | Mar 31, 2018 | $7.91M | -47.7% |
| Q4 FY2017 | Dec 31, 2017 | $94.69M | +624.0% |
| Q3 FY2017 | Sep 30, 2017 | $9.90M | +68.3% |
| Q2 FY2017 | Jun 30, 2017 | $6.61M | – |
| Q1 FY2017 | Mar 31, 2017 | $15.13M | – |
| Q4 FY2016 | Dec 31, 2016 | $13.08M | – |
| Q3 FY2016 | Sep 30, 2016 | $5.88M | – |
See a number that looks wrong?